CN116606393A - 两亲性化合物、以及使用了其的医疗用树脂组合物和药品添加剂 - Google Patents

两亲性化合物、以及使用了其的医疗用树脂组合物和药品添加剂 Download PDF

Info

Publication number
CN116606393A
CN116606393A CN202310509657.XA CN202310509657A CN116606393A CN 116606393 A CN116606393 A CN 116606393A CN 202310509657 A CN202310509657 A CN 202310509657A CN 116606393 A CN116606393 A CN 116606393A
Authority
CN
China
Prior art keywords
amphiphilic compound
group
polymer
carbon atoms
structural unit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202310509657.XA
Other languages
English (en)
Chinese (zh)
Inventor
今瀬将人
佐藤茜
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Shokubai Co Ltd
Original Assignee
Nippon Shokubai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shokubai Co Ltd filed Critical Nippon Shokubai Co Ltd
Publication of CN116606393A publication Critical patent/CN116606393A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F120/00—Homopolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride, ester, amide, imide or nitrile thereof
    • C08F120/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F120/10—Esters
    • C08F120/20—Esters of polyhydric alcohols or polyhydric phenols, e.g. 2-hydroxyethyl (meth)acrylate or glycerol mono-(meth)acrylate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F126/00—Homopolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen
    • C08F126/06—Homopolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen by a heterocyclic ring containing nitrogen
    • C08F126/08—N-Vinyl-pyrrolidine
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F20/00—Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride, ester, amide, imide or nitrile thereof
    • C08F20/02—Monocarboxylic acids having less than ten carbon atoms, Derivatives thereof
    • C08F20/10—Esters
    • C08F20/20—Esters of polyhydric alcohols or polyhydric phenols, e.g. 2-hydroxyethyl (meth)acrylate or glycerol mono-(meth)acrylate
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L33/00—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • C08L33/04—Homopolymers or copolymers of esters
    • C08L33/14—Homopolymers or copolymers of esters of esters containing halogen, nitrogen, sulfur, or oxygen atoms in addition to the carboxy oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
CN202310509657.XA 2019-03-29 2020-03-30 两亲性化合物、以及使用了其的医疗用树脂组合物和药品添加剂 Pending CN116606393A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2019067826 2019-03-29
JP2019-067826 2019-03-29
PCT/JP2020/014668 WO2020203998A1 (ja) 2019-03-29 2020-03-30 両親媒性化合物、並びにこれを用いた医療用樹脂組成物および医薬品添加剤
CN202080024959.2A CN113646341B (zh) 2019-03-29 2020-03-30 两亲性化合物、以及使用了其的医疗用树脂组合物和药品添加剂

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN202080024959.2A Division CN113646341B (zh) 2019-03-29 2020-03-30 两亲性化合物、以及使用了其的医疗用树脂组合物和药品添加剂

Publications (1)

Publication Number Publication Date
CN116606393A true CN116606393A (zh) 2023-08-18

Family

ID=72668997

Family Applications (3)

Application Number Title Priority Date Filing Date
CN202310509657.XA Pending CN116606393A (zh) 2019-03-29 2020-03-30 两亲性化合物、以及使用了其的医疗用树脂组合物和药品添加剂
CN202080024959.2A Active CN113646341B (zh) 2019-03-29 2020-03-30 两亲性化合物、以及使用了其的医疗用树脂组合物和药品添加剂
CN202310509663.5A Pending CN116589702A (zh) 2019-03-29 2020-03-30 两亲性化合物、以及使用了其的医疗用树脂组合物和药品添加剂

Family Applications After (2)

Application Number Title Priority Date Filing Date
CN202080024959.2A Active CN113646341B (zh) 2019-03-29 2020-03-30 两亲性化合物、以及使用了其的医疗用树脂组合物和药品添加剂
CN202310509663.5A Pending CN116589702A (zh) 2019-03-29 2020-03-30 两亲性化合物、以及使用了其的医疗用树脂组合物和药品添加剂

Country Status (6)

Country Link
US (1) US12297302B2 (https=)
EP (1) EP3950735A4 (https=)
JP (2) JP7250907B2 (https=)
CN (3) CN116606393A (https=)
CA (1) CA3134852A1 (https=)
WO (1) WO2020203998A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022161408A (ja) * 2021-04-09 2022-10-21 株式会社日本触媒 血液または血小板保存容器
JP7778816B2 (ja) * 2021-12-15 2025-12-02 株式会社日本触媒 コンジュゲート化合物およびコンジュゲート化合物の製造方法
WO2025022920A1 (ja) * 2023-07-26 2025-01-30 株式会社日本触媒 脂質ナノ粒子

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4529786A (en) * 1981-03-30 1985-07-16 Celanese Corporation Acrylate and methacrylate monoesters of pentaerythritol and pentaerythritol orthoesters and polymers and copolymers derived therefrom
CN1371481A (zh) * 1999-09-02 2002-09-25 爱尔康公司 用作外科植入物的共价键合的亲水性涂层组合物
CN102099387A (zh) * 2008-05-29 2011-06-15 联合利华公司 两亲性支化聚合物及其作为乳化剂的用途
US20130046052A1 (en) * 2010-03-10 2013-02-21 The University Of Sheffield Polymer Synthesis
CN103003377A (zh) * 2010-07-24 2013-03-27 株式会社日本触媒 亲水化处理剂
US20190218323A1 (en) * 2016-08-08 2019-07-18 The University Of Liverpool Branched polymers

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4071508A (en) * 1975-02-11 1978-01-31 Plastomedical Sciences, Inc. Anionic hydrogels based on hydroxyalkyl acrylates and methacrylates
US4855369A (en) * 1985-12-11 1989-08-08 Exxon Chemical Patents Inc. High solids acrylic-based coatings
DE19525031A1 (de) * 1995-07-10 1997-01-16 Heraeus Kulzer Gmbh Derivate aromatischer Carbonsäuren, aromatische Carbonsäureanhydride und Hydroxy(meth)acrylaten sowie Adhäsive, enthaltend diese Verbindungen
US6632905B2 (en) 1999-09-02 2003-10-14 Alcon Universal Ltd. Covalently-bound, hydrophilic coating compositions for surgical implants
AU2002353485B2 (en) * 2001-12-04 2009-01-15 Ben Gurion University Of The Negev Research And Development Authority Amphiphilic compounds and vesicles/liposomes for organ-specific drug targeting
US20080019918A1 (en) * 2004-09-10 2008-01-24 Takao Aoki Medicinal Preparation
TW200835662A (en) 2006-12-22 2008-09-01 Sekisui Chemical Co Ltd Glass paste
US20080314767A1 (en) * 2007-06-22 2008-12-25 Bausch & Lomb Incorporated Ophthalmic Solutions
JP5538315B2 (ja) 2011-07-20 2014-07-02 桜宮化学株式会社 エマルジョン燃料
JP6887713B2 (ja) * 2016-06-16 2021-06-16 エルジー・ケム・リミテッド 両親媒性高分子
JP7076971B2 (ja) 2017-09-28 2022-05-30 キヤノン株式会社 撮像装置およびその製造方法ならびに機器

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4529786A (en) * 1981-03-30 1985-07-16 Celanese Corporation Acrylate and methacrylate monoesters of pentaerythritol and pentaerythritol orthoesters and polymers and copolymers derived therefrom
CN1371481A (zh) * 1999-09-02 2002-09-25 爱尔康公司 用作外科植入物的共价键合的亲水性涂层组合物
CN102099387A (zh) * 2008-05-29 2011-06-15 联合利华公司 两亲性支化聚合物及其作为乳化剂的用途
US20130046052A1 (en) * 2010-03-10 2013-02-21 The University Of Sheffield Polymer Synthesis
CN103003377A (zh) * 2010-07-24 2013-03-27 株式会社日本触媒 亲水化处理剂
US20190218323A1 (en) * 2016-08-08 2019-07-18 The University Of Liverpool Branched polymers

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
A. BLANAZS等: ""Predictive Phase Diagrams for RAFT Aqueous Dispersion Polymerization: Effect of Block Copolymer Composition, Molecular Weight, and Copolymer Concentration"", MACROMOLECULES, vol. 45, no. 12, 13 June 2012 (2012-06-13), pages 5099 - 5107 *
周成飞;: "大分子单体的合成方法及其在辐射聚合方面应用的研究进展Ⅰ.大分子单体的合成方法", 合成技术及应用, no. 04, 28 December 2012 (2012-12-28), pages 26 - 32 *
张瑶瑶;王小辉;霍菲;张望清;: "可逆加成-断裂链转移(RAFT)分散聚合", 高分子通报, no. 01, 15 January 2013 (2013-01-15) *

Also Published As

Publication number Publication date
JP7684343B2 (ja) 2025-05-27
CA3134852A1 (en) 2020-10-08
EP3950735A4 (en) 2023-01-04
JP7250907B2 (ja) 2023-04-03
US12297302B2 (en) 2025-05-13
CN113646341A (zh) 2021-11-12
US20220185918A1 (en) 2022-06-16
WO2020203998A1 (ja) 2020-10-08
JPWO2020203998A1 (https=) 2020-10-08
CN116589702A (zh) 2023-08-15
JP2023076520A (ja) 2023-06-01
EP3950735A1 (en) 2022-02-09
CN113646341B (zh) 2023-04-18

Similar Documents

Publication Publication Date Title
JP7684343B2 (ja) 両親媒性化合物、並びにこれを用いた医療用樹脂組成物および医薬品添加剤
JP5512780B2 (ja) 脂質膜による微粒子の被覆方法
Xu et al. The Bifunctional Liposomes Constructed by Poly (2-ethyl-oxazoline)-cholesteryl Methyl Carbonate: an Effectual Approach to Enhance Liposomal Circulation Time, pH-Sensitivity and Endosomal Escape: Xu et al.
CN1812766A (zh) 用于全身传递使生长停滞的、衍生于脂质的生物活性化合物的方法和系统
Monteiro et al. On the use of dexamethasone‐loaded liposomes to induce the osteogenic differentiation of human mesenchymal stem cells
US10182987B2 (en) Lipid membrane structure for intracellular delivery of siRNA
CN104622817B (zh) 一种蛋白‑聚合物复合纳米载体及其制备方法
US20120301539A1 (en) Method of producing coated fine particles
WO2005089926A1 (ja) 被覆微粒子の製造方法
JP3308010B2 (ja) 被膜安定化リポソーム及びその製造方法
CN117427174B (zh) 一种用于核酸药物的复合材料及其制备方法和应用
Scialabba et al. Exploiting inhalable microparticles incorporating hybrid polymer-lipid nanoparticles loaded with Iloprost manages lung hyper-inflammation
Ning et al. Carboxymethyl dextran-coated liposomes: Toward a robust drug delivery platform
WO2005092388A1 (ja) リポソーム製剤
JP4723380B2 (ja) ポリエチレングリコール誘導体及びこれを膜構成成分とする薬物担体
CN117534585B (zh) 一种可电离阳离子脂质化合物及其制备方法与应用
US9937127B2 (en) Method of producing fine particles surface-modified with water-soluble substance
US20090010999A1 (en) Complex Particles and Coated Complex Particles
JP6777390B2 (ja) 生体適合性医療用材料
WO2025022920A1 (ja) 脂質ナノ粒子
JPWO2006077857A1 (ja) 粒子を脂質膜で被覆する方法
Wang et al. Synthesis of diacylglycerol‐terminated lipid–polymer conjugates: application to cell surface modification
JP7411371B2 (ja) 糖鎖修飾ポリマーおよびその製造方法、並びにこれを用いた医療用樹脂組成物および医薬品添加剤
Naderkhani Investigation and optimization of liposome formulation for use as drug carrier for the anticancer agent Camptothecin
JP2015189682A (ja) 抗ウイルス剤

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20230818